GliaSite 1-3 Mets Study

Clinical trial NCT00589212 · COMPLETED

Trial details

NCT number: NCT00589212
Sponsor: Hologic, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Brain Metastases

Start date: 2003-10-01
Primary completion: 2007-03-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.